Clinical Trials Browser

INDUSTRY × Solid Tumor × Irinotecan × Clear all

NCT02250157 2022-02-22

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT01463982 2015-04-23

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Phase 1 Completed

21 enrolled 10 charts

Other solid neoplasm

Solid Tumor